The month of March began strong with the Dow jumping 155 points to 18,288. Nasdaq soared 44 points to close at 5,008, topping 5,000 for the first time in fifteen years.
On the upside
Tracon Pharmaceuticals (Nasdaq: TCON) reported positive results from a Phase 1b clinical trial of TRC105 with Inlyta(R) in patients with advanced or metastatic renal cell carcinoma.
Cisco Systems (Nasdaq: CSCO) introduced its Universal Small Cell (USC) 8000 Series for large enterprises.
Bargain hunters lifted shares of 500.com (NYSE: WBAI).
On the downside
Goodrich Petroleum (NYSE: GDP) will offer 12 million shares of common stock.
BioScrip (Nasdaq: BIOS) widened fourth quarter losses more than expected.
The Food and Drug Administration issued a Complete Response Letter to Pacira Pharmaceuticals (Nasdaq: PCRX) for its supplemental New Drug Application for the expanded use of Exparel.
In the broad market, advancing issues outpaced decliners by a margin of nearly 3 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 climbed 12 points to 2117. Bitcoin climbed $16 to $271.
Strong March open
March 02, 2015 at 16:53 PM EST